Case Report
Published on 09 Apr 2025
CD20-positive peripheral T-cell lymphoma not otherwise specified: a case series and review of the literature
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1553969
Type at least 3 characters
1,816 articles
Review
Accepted on 07 Apr 2025
Preventing Pneumococcal Infections in Patients With Hematological Malignancies: A Review of Evidence and Recommendations Based on Modified Delphi Consensus
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1546641
Original Research
Published on 07 Apr 2025
Artificial intelligence-assisted early screening of acute promyelocytic leukaemia in blood smears: a prospective evaluation of MC-100i
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1572838
- 222 views
Case Report
Published on 07 Apr 2025
Case Report: Radiological characteristics and pathological correlation analysis of extranodal Rosai-Dorfman disease of liver
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1484820
- 114 views
Review
Accepted on 03 Apr 2025
A potential prognostic marker for hematologic neoplasms: CD58
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1586842
Case Report
Accepted on 03 Apr 2025
Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e13a3 fusion transcripts in a Patient with Pre-existing Essential Thrombocythemia: A Case Report and Literature Review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1573893
Perspective
Published on 01 Apr 2025
Total skin electron beam therapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1498855
- 181 views
Case Report
Published on 01 Apr 2025
18F-FDG PET/CT in the diagnosis and treatment of atypical extensive skin lesions in extranodal natural killer/T-cell lymphoma, nasal type: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1480661
- 153 views
Review
Accepted on 31 Mar 2025
Targeting BCL2 in Waldenström Macroglobulinemia: From biology to treatment management
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1564869
Original Research
Published on 31 Mar 2025
Increased TIGIT expression correlates with impaired NK cell function in diffuse large B-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1551061
- 292 views
Original Research
Published on 31 Mar 2025
The association of FAT1 mutations with therapeutic outcomes in AML, especially in receiving venetoclax combination
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1456832
- 214 views
Editorial
Published on 27 Mar 2025
Editorial: Elderly patients and lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1568846
- 220 views
Case Report
Published on 27 Mar 2025
Case Report: Decitabine and venetoclax sequentially followed by FLAG-Ida and venetoclax with immediate allogeneic stem cell transplantation in newly diagnosed acute myeloid leukemia with chromosome 3 inversion/MECOM rearrangement
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1530852
- 420 views
Original Research
Accepted on 26 Mar 2025
TP53 mutation and immunohistochemical p53 expression characteristics in diffuse large B-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1550207
Case Report
Published on 25 Mar 2025
Endoscopic ultrasound-guided fine-needle aspiration in diagnosing primary medistinal large B-cell lymphoma: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1404211
- 230 views
Brief Research Report
Published on 25 Mar 2025
Identification of a novel NRF1::PDGFRA fusion in myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1552928
- 240 views